420 Cost Minimisation of Respiratory Syncitial Virus Prophylaxis With Palivizumab

Pediatric Research - United States
doi 10.1203/00006450-200508000-00449
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy